Favorite Annette F 4

What Happened

• Annette F. Favorite, Senior Vice President and Chief HR Officer of West Pharmaceutical Services (WST), exercised 2,817 options and sold the resulting 2,817 shares on April 27, 2026. The exercise was recorded at $83.47 per share (total cost ~$235,135) and the open-market sale was at a weighted average price of $305.20 per share (gross proceeds ~$859,753). A related derivative line shows 2,817 shares disposed at $0, which commonly reflects share withholding or net settlement related to the exercise.

Key Details

• Transaction date: April 27, 2026
• Exercise (M): 2,817 shares acquired at $83.47/share — $235,135 total
• Sale (S): 2,817 shares sold at weighted avg $305.20/share — $859,753 total
• Derivative disposition: 2,817 shares at $0 (likely withholding/net settlement)
• Footnotes: F1 — reported sale price is a weighted average; F2 — the award traces to a Feb 21, 2017 grant that vested in four equal annual installments beginning Feb 21, 2018.
• Shares owned after the transactions: not disclosed in the provided excerpt.
• Filing timeliness: Report filed Apr 29, 2026 for Apr 27 transactions — appears to be a timely Form 4 filing (within the usual 2-business-day window).

Context

• This sequence (exercise followed by same-day sale of all shares) functions like a cashless exercise: the insider converted vested equity to cash rather than adding to an ongoing ownership stake. Per the footnote, the exercised options originated from a 2017 award that vested over time, indicating these were vested shares being cashed out rather than a new grant. Such transactions are common for executives to realize proceeds or cover tax/option costs and are not, by themselves, a directional signal about company outlook.